NCT04353869View on ClinicalTrials.gov

Targeting Glutamine Metabolism to Prevent Diabetic Cardiovascular Complications

CompletedOBSERVATIONAL
Enrollment

995

Participants

Timeline

Start Date

November 16, 2020

Primary Completion Date

January 10, 2024

Study Completion Date

January 10, 2024

Conditions
GlutamineDiabeticCardiovascular Complications
Interventions
BIOLOGICAL

Bio collection

venous blood sampling and collection of urine

Trial Locations (2)

75010

Diabétologie - Hôpital Lariboisière, Paris

75018

Diabetologie Bichat, Paris

All Listed Sponsors
collaborator

National Research Agency, France

OTHER

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT04353869 - Targeting Glutamine Metabolism to Prevent Diabetic Cardiovascular Complications | Biotech Hunter | Biotech Hunter